2015

1. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

   Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338